Senior Manager
Current# Bio/Healthcare Investment - Accent Therapeutics ('24.01, Series C)
Jun 2023 - Present
AeroLeads people directory · profile
Daniel Kwon Email & Phone Number
Investment & BD Professional (Venture investment, Licensing, M&A)
at
Mirae Asset Capital
LinkedIn matched
✓ Verified July 2026
3 data sources
Profile completeness 86%
Current company
Role
Investment & BD Professional (Venture investment, Licensing, M&A)
Location
Seoul, South Korea, Korea, Republic of
Who is Daniel Kwon? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Daniel Kwon is listed as Investment & BD Professional (Venture investment, Licensing, M&A) at Mirae Asset Capital, based in Seoul, South Korea, Korea, Republic of. AeroLeads shows a matched LinkedIn profile for Daniel Kwon.
Daniel Kwon previously worked as Senior Manager at Mirae Asset Capital and Senior Investment Manager at Samsung Venture Investment. Daniel Kwon holds Master Of Pharmacy from Kyung Hee University 경희대학교.
Company email context
Email format at Mirae Asset Capital
This section adds company-level context without repeating Daniel Kwon's masked contact details.
Mirae Asset Capital
Review company-level records connected to Daniel Kwon before choosing the right outreach path.
Profile bio
About Daniel Kwon
Spacious Networks/Working experience in Pharma-industries / Work Experience/Knowledge about the diverse department & Communication skill (Development, Research, Production, Marketing)
Current workplace
Daniel Kwon's current company
Company context helps verify the profile and gives searchers a useful next step.
4 roles
Daniel Kwon work experience
A career timeline built from the work history available for this profile.
Senior Investment Manager
# Bio/Healthcare Investment - Strategic investment for Samsung's Bio business affiliates - Financial investment - Market Intelligence for focused investment area - Achievement: Senda Biosciences (Series C, $15M), Araris Biotech AG (Pre-A, undisclosed)# New Fund raised - New CVC fund raised (\20B Korean Won)
Feb 2022 - Jun 2023
Senior Bd Manager
# Open Innovation (R&D pipeline Licensing and strategic partnership) - NASH and Metabolic pipeline sourcing, review, business development - Oncology and Cell & Gene Therapy, Business development - Research market intelligence and internal reports - Leading due diligence and contract negotiation - Achievements: NASH asset licensing ('20.08)# Licensing Out - Commercial/Research stage pipeline out-licensing - Make long/short list of specific research area/territory and contact - Contract negotiation and execution - Achievement: Clinical asset L/O to Korean biotech ('19.02), Commercial asset L/O to Brazilian company ('20.09)# Managing internal/external Funds - Cooperate with internal financing and relevant team to report Management Team - Close communication with external/internal open innovation channel including PEF GP - Interact with Global Venture Capitals
May 2018 - Feb 2022
Global Business Development Manager
# Portfolio Management & Developing New product pipeline - New product market research (Global including KR, CN, TH, VN, IN) - Sales forecasting and evaluation of profitability using DCF - Managing the product portfolio and New pipeline suggestion/planning/development - Managing internal development pert # New Business strategy Planning (Corporate global Business) - Product portfolio development of overseas affiliates - Analysis of China insurance/tender system and planning/development of new products - Collaboration with Local (China) Pharmaceutical university & research center - KOL/CFDA/CRO meeting for market/regulatory feasibility analysis - Investment feasibility analysis for new product, comparison with Korean manufacturer # New Business strategy Planning (CDMO, M&A, JV) - CDMO business planning : Analysis of local pharmaceutical companies and FDI environment : Review and analysis of current business portfolio and partner pool, business structure : Business development (Pool-up, Contact, Nego), Target product portfolio development - Merge and Acquisition (M&A), Strategic Investments : Company profile review, Advisor contracts, FDI (foreign direct investment) regulation and industrial environment analysis, Due diligence coordination, Synergy plan development, PMI (Post merge integration) strategy planning, Negotiation with target company with partners, Valuation : Collaboration with VC, IB, Financial advisors, Legal advisors
Jan 2013 - Apr 2018
2 education records
Daniel Kwon education
Master Of Pharmacy
학사 (Bachelor)
FAQ
Frequently asked questions about Daniel Kwon
Quick answers generated from the profile data available on this page.
What company does Daniel Kwon work for?
Daniel Kwon works for Mirae Asset Capital.
What is Daniel Kwon's role at Mirae Asset Capital?
Daniel Kwon is listed as Investment & BD Professional (Venture investment, Licensing, M&A) at Mirae Asset Capital.
Where is Daniel Kwon based?
Daniel Kwon is based in Seoul, South Korea, Korea, Republic of while working with Mirae Asset Capital.
What companies has Daniel Kwon worked for?
Daniel Kwon has worked for Mirae Asset Capital, Samsung Venture Investment, Lg Chem Life Sciences, and Daewoong Pharmaceuticals.
How can I contact Daniel Kwon?
You can use AeroLeads to view verified contact signals for Daniel Kwon at Mirae Asset Capital, including work email, phone, and LinkedIn data when available.
What schools did Daniel Kwon attend?
Daniel Kwon holds Master Of Pharmacy from Kyung Hee University 경희대학교.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialPeople with similar names
Check these profiles if this is not the Daniel Kwon you were looking for.
View similar profiles
